General Pharmacology — MCQs
On this page
Which of the following is a true statement about Phase 2 clinical trials?
Following an overdose of an over-the-counter (OTC) drug, a young college student presents with marked gastrointestinal distress, lethargy, confusion, and elevated body temperature. Laboratory analysis of blood reveals a low pCO2, low HCO3-, low K+, and an anion gap acidosis. The most likely cause of these signs and symptoms is a toxic dose of:
Which of the following is a prodrug?
Which of the following drugs exhibits saturable kinetics?
Which of the following is an immunostimulant?
What is the primary mechanism of action of local anesthetics?
What is the preferred site for intramuscular injection?
Ketamine can be used in all of the following situations except:
Hoffmann's elimination is characteristic of which of the following drugs?
Olopatadine acts as an:
General Pharmacology Indian Medical PG Practice Questions and MCQs
Question 191: Which of the following is a true statement about Phase 2 clinical trials?
- A. A large number of healthy volunteers are studied.
- B. It is used to determine the maximum tolerated dose.
- C. It is used to determine efficacy. (Correct Answer)
- D. It is used to determine toxicity.
Explanation: **Explanation:** Clinical trials are conducted in sequential phases to ensure drug safety and effectiveness. **Phase 2 trials** are primarily designed to evaluate the **therapeutic efficacy** of a drug in a specific patient population. * **Why Option C is Correct:** Phase 2 is known as the "Proof of Concept" phase. It involves a small group of patients (typically 100–300) who actually have the target disease. The goal is to determine if the drug produces the desired clinical effect and to establish the optimal dosage range for larger studies. * **Why Other Options are Incorrect:** * **Option A:** Studying a large number of healthy volunteers describes **Phase 1** (for safety/pharmacokinetics) or **Phase 3** (for large-scale efficacy). Phase 2 uses a limited number of *patients*, not healthy volunteers. * **Option B:** Determining the **Maximum Tolerated Dose (MTD)** is the primary objective of **Phase 1** trials. * **Option D:** While safety is monitored in all phases, the primary focus on **toxicity and safety profile** in humans begins in **Phase 1**. **High-Yield NEET-PG Pearls:** * **Phase 0:** Human Microdosing (sub-therapeutic doses) to study pharmacokinetics. * **Phase 1:** Safety, Tolerability, MTD, and Pharmacokinetics (usually in healthy volunteers, except for oncology drugs). * **Phase 2:** Efficacy and Dose-ranging (in patients). * **Phase 3:** Confirmatory trial; compares the new drug against the "Gold Standard" (RCT). * **Phase 4:** Post-marketing surveillance; detects rare side effects (e.g., Phocomelia, Rofecoxib cardiotoxicity).
Question 192: Following an overdose of an over-the-counter (OTC) drug, a young college student presents with marked gastrointestinal distress, lethargy, confusion, and elevated body temperature. Laboratory analysis of blood reveals a low pCO2, low HCO3-, low K+, and an anion gap acidosis. The most likely cause of these signs and symptoms is a toxic dose of:
- A. acetaminophen
- B. acetylsalicylic acid (Correct Answer)
- C. diphenhydramine
- D. pseudoephedrine
Explanation: **Explanation:** The clinical presentation described is a classic case of **Salicylate (Acetylsalicylic acid) poisoning**. **Why Acetylsalicylic Acid is Correct:** Salicylates cause a complex acid-base disturbance characterized by a **"Mixed Respiratory Alkalosis and Metabolic Acidosis."** 1. **Respiratory Alkalosis:** Salicylates directly stimulate the medullary respiratory center, causing hyperventilation. This leads to a decrease in pCO2 (low pCO2). 2. **Anion Gap Metabolic Acidosis (AGMA):** Salicylates uncouple oxidative phosphorylation, leading to anaerobic metabolism and the accumulation of organic acids (lactic acid, ketoacids). This results in a high anion gap and low HCO3-. 3. **Other features:** Hyperpyrexia (due to uncoupling of oxidative phosphorylation), hypokalemia (due to renal loss), and CNS symptoms (confusion/lethargy) are hallmark signs of toxicity. **Why Other Options are Incorrect:** * **Acetaminophen:** Toxicity primarily causes **hepatotoxicity** (elevated ALT/AST). While it can cause metabolic acidosis in very late stages (liver failure), it does not typically cause the initial respiratory alkalosis or hyperpyrexia seen here. * **Diphenhydramine:** An antihistamine that presents with **anticholinergic toxicity** ("mad as a hatter, hot as a hare, dry as a bone"). It does not cause a high anion gap metabolic acidosis. * **Pseudoephedrine:** A sympathomimetic that causes hypertension, tachycardia, and agitation, but not the specific mixed acid-base disorder described. **NEET-PG High-Yield Pearls:** * **Done Nomogram:** Used to estimate the severity of salicylate poisoning (though clinical correlation is preferred). * **Treatment:** Gastric lavage and **Urinary Alkalinization** (using IV Sodium Bicarbonate) to enhance renal excretion via "ion trapping." * **Tinnitus:** Often the earliest sign of salicylate toxicity.
Question 193: Which of the following is a prodrug?
- A. Levodopa (Correct Answer)
- B. Amitriptyline
- C. Primidone
- D. Digitoxin
Explanation: **Explanation:** A **prodrug** is a pharmacologically inactive compound that must undergo chemical or enzymatic biotransformation within the body to be converted into its active form. **Why Levodopa is the correct answer:** Levodopa is the classic example of a prodrug used in Parkinsonism. It is an amino acid precursor that crosses the blood-brain barrier (BBB) via large neutral amino acid transporters. Once inside the CNS, it undergoes **decarboxylation** by the enzyme *L-amino acid decarboxylase* to become **Dopamine**, which is the active moiety. Dopamine itself cannot be administered directly because it is polar and cannot cross the BBB. **Analysis of Incorrect Options:** * **Amitriptyline:** It is an active Tricyclic Antidepressant (TCA). While it is metabolized into another active metabolite (Nortriptyline), the parent drug itself possesses pharmacological activity. * **Primidone:** It is an anticonvulsant that is metabolized into Phenobarbital and Phenylethylmalonamide (PEMA). However, Primidone itself has independent anticonvulsant activity and is not strictly a prodrug. * **Digitoxin:** This is an active cardiac glycoside. Unlike its counterpart Digoxin, it undergoes extensive hepatic metabolism, but it is active upon administration. **NEET-PG High-Yield Pearls:** * **Common Prodrugs (Mnemonic: "All Prefer Drugs In Car"):** **A**CE inhibitors (except Captopril/Lisinopril), **P**rednisone, **D**ipivefrin, **I**rinotecan, **C**yclophosphamide/Clopidogrel. * **Enalapril** is a prodrug; its active form is **Enalaprilat**. * **Terfenadine** is a prodrug; its active form is **Fexofenadine**. * Prodrugs are often designed to improve bioavailability, reduce first-pass metabolism, or facilitate site-specific delivery (like Levodopa to the brain).
Question 194: Which of the following drugs exhibits saturable kinetics?
- A. Phenytoin (Correct Answer)
- B. Diazepam
- C. Digoxin
- D. Barbiturate
Explanation: ### Explanation **Correct Option: A (Phenytoin)** Phenytoin exhibits **Zero-Order Kinetics** (also known as saturable, non-linear, or capacity-limited kinetics) at therapeutic or high concentrations. * **The Concept:** Most drugs follow first-order kinetics, where a constant *fraction* of the drug is eliminated per unit time. However, in zero-order kinetics, the metabolic enzymes (CYP2C9/19 for Phenytoin) become saturated. Once saturated, the body eliminates a constant *amount* of the drug regardless of the plasma concentration. * **Clinical Significance:** Small dose increases can lead to disproportionately large increases in plasma levels, significantly increasing the risk of toxicity. **Incorrect Options:** * **B (Diazepam):** Follows **First-Order Kinetics**. Its elimination rate is proportional to its plasma concentration; as the dose increases, the clearance remains constant. * **C (Digoxin):** Follows **First-Order Kinetics**. It has a large volume of distribution and is primarily excreted unchanged by the kidneys. * **D (Barbiturates):** Most barbiturates (like Phenobarbital) follow **First-Order Kinetics**. Note: While ultra-short-acting barbiturates like Thiopental show zero-order kinetics in massive overdose, Phenytoin is the classic prototype for saturable kinetics at therapeutic ranges. **NEET-PG High-Yield Pearls:** * **Mnemonic for Zero-Order Drugs:** **"7-UP"** or **"WATT"** * **W**arfarin (at high doses) * **A**lcohol (Ethanol) / **A**spirin (Salicylates) * **T**heophylline / **T**olbutamide * **T**he **P**henytoin (Most common exam answer) * **Key Feature:** In zero-order kinetics, the **Half-life ($t_{1/2}$)** is not constant; it increases as the dose/plasma concentration increases.
Question 195: Which of the following is an immunostimulant?
- A. Methimazole
- B. Levamisole (Correct Answer)
- C. Ketoconazole
- D. Zidovudine
Explanation: **Explanation:** **Levamisole** is the correct answer. Originally developed as an anthelmintic (anti-worm) medication, it was discovered to have potent **immunomodulatory** properties. It acts as an **immunostimulant** by restoring depressed T-cell and macrophage functions. It enhances phagocytosis, T-cell proliferation, and chemotaxis. * **Clinical Use:** Historically, it was used as an adjuvant in colorectal cancer (with 5-Fluorouracil) and in certain autoimmune conditions. In modern practice, it is occasionally used in pediatric nephrotic syndrome (frequent relapsers) to maintain remission. **Analysis of Incorrect Options:** * **A. Methimazole:** This is an **antithyroid drug** (Thionamide). It inhibits the enzyme thyroid peroxidase, preventing the synthesis of T3 and T4. It is a primary treatment for hyperthyroidism (Graves' disease). * **C. Ketoconazole:** This is an **imidazole antifungal** agent. It works by inhibiting the fungal enzyme 14-alpha-demethylase, blocking ergosterol synthesis. In high doses, it also inhibits steroid synthesis in humans (used in Cushing’s syndrome). * **D. Zidovudine (AZT):** This is a **Nucleoside Reverse Transcriptase Inhibitor (NRTI)** used in the treatment of HIV/AIDS. It inhibits viral DNA synthesis. **High-Yield Pearls for NEET-PG:** 1. **Levamisole Side Effect:** A classic board-favorite side effect is **agranulocytosis**. 2. **Other Immunostimulants:** Remember **Thalidomide** (used in ENL), **BCG vaccine** (used intravesically for bladder cancer), and **Interferons** (IFN-α for Hepatitis B/C). 3. **Levamisole "Adulterant":** It is frequently found as a contaminant in illicit cocaine, leading to a characteristic "retiform purpura" (skin necrosis).
Question 196: What is the primary mechanism of action of local anesthetics?
- A. Inhibition of Na+ channels (Correct Answer)
- B. Inhibition of Na+ K+ ATPase
- C. Inhibition of K+ channels
- D. Inhibition of Ca2+ channels
Explanation: **Explanation:** **Mechanism of Action:** Local anesthetics (LAs) work by blocking **voltage-gated sodium (Na+) channels** on the inner surface of the neuronal membrane [1]. They exist in an equilibrium between an uncharged (lipid-soluble) form and a charged (active) form. The uncharged form diffuses across the axonal membrane and then re-ionizes. This charged molecule binds to the **S6 segment of Domain IV** of the sodium channel, preventing the influx of Na+ ions. This inhibits depolarization, preventing the generation and propagation of the action potential (the "membrane stabilizing" effect) [1]. **Analysis of Options:** * **B. Inhibition of Na+ K+ ATPase:** This is the mechanism of **Cardiac Glycosides (Digoxin)**. While this pump maintains the resting membrane potential, LAs do not target it. * **C. Inhibition of K+ channels:** K+ channel blockers (like **Amiodarone**) are primarily used as Class III antiarrhythmics to prolong repolarization. While LAs can block K+ channels, this requires significantly higher concentrations than those needed for Na+ block [3]. * **D. Inhibition of Ca2+ channels:** Ca2+ channel blockers (like **Verapamil**) are used for hypertension and arrhythmias. While some LAs have weak effects on other channels at high doses, their primary anesthetic effect is Na+ specific [1]. **High-Yield Clinical Pearls for NEET-PG:** * **State-Dependent Block:** LAs have a higher affinity for channels in the **activated (open)** or **inactivated** states rather than the resting state [2]. This is why rapidly firing fibers are blocked first. * **Order of Blockade:** Generally, smaller and myelinated fibers are blocked first. The sequence is: **Autonomic > Pain > Temperature > Touch > Deep Pressure > Motor.** * **pH Effect:** LAs are weak bases. In **inflamed/acidic tissues**, more LA remains in the ionized form outside the cell, preventing it from crossing the membrane, which leads to **decreased efficacy**. * **Bupivacaine** is the most cardiotoxic LA; **Levobupivacaine** and **Ropivacaine** are safer alternatives.
Question 197: What is the preferred site for intramuscular injection?
- A. Deltoid muscle
- B. Anterolateral aspect of the thigh
- C. Upper outer quadrant of the buttocks (Correct Answer)
- D. Upper inner quadrant of the buttocks
Explanation: **Explanation:** The **upper outer quadrant of the gluteal region** (buttocks) is the preferred site for intramuscular (IM) injections in adults because it provides a large muscle mass (gluteus maximus) capable of absorbing significant drug volumes (up to 5 ml). More importantly, this specific quadrant is chosen to **avoid injury to the sciatic nerve** and the superior gluteal artery, which are located in the deeper and more medial aspects of the buttocks. **Analysis of Options:** * **Option A (Deltoid):** While commonly used for vaccines, the deltoid has a smaller muscle volume (max 1–2 ml) and carries a risk of injury to the axillary nerve if not localized correctly. * **Option B (Anterolateral Thigh):** This refers to the **Vastus Lateralis**. While it is the **preferred site for infants and neonates** (due to well-developed muscle at birth and lack of major nerves), it is not the primary choice for general IM injections in adults unless the gluteal site is contraindicated. * **Option D (Upper inner quadrant):** This is dangerous and incorrect, as it lies directly over the path of the sciatic nerve, risking permanent nerve palsy. **NEET-PG High-Yield Pearls:** 1. **Ventrogluteal site:** Modern clinical practice often considers the ventrogluteal site (gluteus medius) safer than the dorsogluteal site because it is further from major nerves and large blood vessels. 2. **Z-track Technique:** Used for drugs that stain the skin (e.g., Iron dextran) to prevent leakage into subcutaneous tissue. 3. **Absorption Rate:** IM absorption is generally faster than subcutaneous but slower than IV. Absorption is faster from the deltoid than from the gluteal region due to higher vascularity.
Question 198: Ketamine can be used in all of the following situations except:
- A. Status asthmaticus
- B. Analgesia and sedation
- C. Obstetric hemorrhage
- D. Ischemic heart disease (Correct Answer)
Explanation: **Explanation:** Ketamine is a unique anesthetic agent that acts as an NMDA receptor antagonist. Its clinical utility and contraindications are primarily governed by its effect on the sympathetic nervous system. **Why Ischemic Heart Disease (IHD) is the Correct Answer:** Ketamine is a **sympathomimetic** agent. It inhibits the reuptake of catecholamines (norepinephrine), leading to an increase in heart rate, cardiac output, and arterial blood pressure. In patients with **Ischemic Heart Disease**, this increases myocardial oxygen demand, which can precipitate myocardial infarction or worsen ischemia. Therefore, it is strictly contraindicated in IHD and severe hypertension. **Analysis of Incorrect Options:** * **Status Asthmaticus:** Ketamine is a potent **bronchodilator**. It is often the induction agent of choice for patients with reactive airway disease or life-threatening asthma. * **Analgesia and Sedation:** Ketamine produces **"Dissociative Anesthesia"** (sensory loss with amnesia). At sub-anesthetic doses, it provides excellent analgesia without significant respiratory depression, making it ideal for short procedures and burn dressings. * **Obstetric Hemorrhage:** Ketamine is preferred in hemorrhagic shock because its sympathomimetic effects help maintain blood pressure. Unlike most induction agents, it does not cause myocardial depression in a healthy heart. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** For induction in patients with **Hypovolemic/Hemorrhagic shock** and **Bronchial Asthma**. * **Hallucinations:** Associated with "Emergence Delirium" (vivid dreams/hallucinations), which can be prevented by co-administering **Benzodiazepines** (e.g., Midazolam). * **Intracranial Pressure (ICP):** Traditionally avoided in head injuries as it increases ICP and Intraocular pressure. * **Secretions:** It increases salivation (Sialagogue effect); pretreatment with Atropine or Glycopyrrolate may be needed.
Question 199: Hoffmann's elimination is characteristic of which of the following drugs?
- A. Atracurium (Correct Answer)
- B. Vecuronium
- C. Pancuronium
- D. Rocuronium
Explanation: ### Explanation **Correct Answer: A. Atracurium** **Concept of Hoffmann’s Elimination:** Hoffmann’s elimination is a unique **spontaneous non-enzymatic chemical degradation** that occurs at physiological pH and temperature. Unlike most drugs that require hepatic metabolism or renal excretion, Atracurium (and its isomer Cisatracurium) breaks down independently in the plasma. This makes it the **drug of choice for patients with liver or kidney failure**, as its clearance remains unaffected by organ dysfunction. **Analysis of Options:** * **Atracurium (Correct):** Undergoes both Hoffmann’s elimination and ester hydrolysis by non-specific plasma esterases. * **Vecuronium (Incorrect):** An intermediate-acting steroid-based muscle relaxant primarily eliminated via **biliary excretion** (liver) and partially by the kidneys. * **Pancuronium (Incorrect):** A long-acting muscle relaxant that is primarily excreted unchanged by the **kidneys**. It is contraindicated in renal failure. * **Rocuronium (Incorrect):** An intermediate-acting drug mainly eliminated by the **liver** (biliary excretion). It is preferred for rapid sequence intubation when Succinylcholine is contraindicated. **High-Yield Clinical Pearls for NEET-PG:** * **Laudanosine Toxicity:** A major metabolite of Atracurium’s Hoffmann elimination is Laudanosine. It can cross the blood-brain barrier and may cause **seizures** (pro-convulsant) if it accumulates during prolonged infusions. * **Cisatracurium:** An isomer of Atracurium that is more potent, undergoes Hoffmann’s elimination, but produces **less Laudanosine** and does not cause histamine release. * **Histamine Release:** Atracurium can trigger histamine release, potentially causing hypotension and bronchospasm; therefore, it should be injected slowly.
Question 200: Olopatadine acts as an:
- A. Antihistaminic (Correct Answer)
- B. Anti-inflammatory
- C. Anti-emetic
- D. Anti-psychotic
Explanation: **Explanation:** **Olopatadine** is a potent, highly selective **second-generation H1-receptor antagonist**. Its primary mechanism involves competitive inhibition of histamine at the H1 receptors. Beyond simple antagonism, it also acts as a **mast cell stabilizer**, preventing the release of inflammatory mediators like histamine, leukotrienes, and prostaglandins from mast cells. This dual action makes it highly effective in treating allergic conditions. **Analysis of Options:** * **A. Antihistaminic (Correct):** Olopatadine is primarily used topically (ophthalmic drops or nasal spray) to treat allergic conjunctivitis and allergic rhinitis. It provides rapid relief from itching and redness by blocking H1 receptors. * **B. Anti-inflammatory:** While it has some mast-cell stabilizing properties that reduce the inflammatory cascade, it is not classified as a primary anti-inflammatory drug (like NSAIDs or Corticosteroids). * **C. Anti-emetic:** H1 blockers used for emesis (like Promethazine or Doxylamine) are typically first-generation antihistamines that cross the blood-brain barrier. Olopatadine is a second-generation agent with minimal CNS penetration. * **D. Anti-psychotic:** Antipsychotics primarily target Dopamine (D2) or Serotonin (5-HT2A) receptors. Olopatadine has no clinical activity at these receptors. **High-Yield Clinical Pearls for NEET-PG:** * **Route:** Most commonly used as **0.1% or 0.2% ophthalmic solution** for seasonal allergic conjunctivitis. * **Generation:** It is a **second-generation** antihistamine, meaning it is non-sedating and does not have significant anticholinergic side effects. * **Dual Action:** Remember it as "Antihistamine + Mast Cell Stabilizer"—a common theme in MCQ exams for drugs like Olopatadine, Ketotifen, and Azelastine.
Practice by Chapter
Pharmacokinetics: Absorption and Distribution
Practice Questions
Pharmacokinetics: Metabolism and Excretion
Practice Questions
Pharmacodynamics and Receptor Theory
Practice Questions
Drug-Receptor Interactions and Dose-Response
Practice Questions
Pharmacogenetics and Personalized Medicine
Practice Questions
Adverse Drug Reactions and Toxicity
Practice Questions
Drug Interactions
Practice Questions
Drug Development and Regulation
Practice Questions
Pediatric and Geriatric Pharmacology
Practice Questions
Placental Transfer and Lactation
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free